يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"Jorge L. Azor-Hernández"', وقت الاستعلام: 0.29s تنقيح النتائج
  1. 1
    Academic Journal
    Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study)

    المؤلفون: Francisco Hernández-Bernal, Maria C. Ricardo-Cobas, Yenima Martín-Bauta, Zadis Navarro-Rodríguez, Marjoris Piñera-Martínez, Joel Quintana-Guerra, Karen Urrutia-Pérez, Klaudia Urrutia-Pérez, Cristina O. Chávez-Chong, Jorge L. Azor-Hernández, José L. Rodríguez-Reinoso, Leonardo Lobaina-Lambert, Elizabeth Colina-Ávila, Jacqueline Bizet-Almeida, Jeniffer Rodríguez-Nuviola, Sergio del Valle-Piñera, Mayara Ramírez-Domínguez, Elisangela Tablada-Ferreiro, Marel Alonso-Valdés, Gilda Lemos-Pérez, Gerardo E. Guillén-Nieto, Ariel Palenzuela-Díaz, Enrique Noa-Romero, Miladys Limonta-Fernández, Juan M. Fernández-Ávila, Nabil A. Ali-Mros, Lianne del Toro-Lahera, Rossana Remedios-Reyes, Marta Ayala-Ávila, Verena L. Muzio-González

    المصدر: EClinicalMedicine, Vol 46, Iss , Pp 101383- (2022)

    مصطلحات موضوعية: Abdala vaccine, COVID-19, SARS-CoV-2, Randomised clinical trial, Medicine (General), R5-920

    وصف الملف: electronic resource

    Relation: http://www.sciencedirect.com/science/article/pii/S2589537022001134; https://doaj.org/toc/2589-5370

    URL الوصول: https://doaj.org/article/701e99cfcb8c4480864eb76aad6725f5

    View record in DOAJ Full Text Finder

    أضف إلى المفضلة
  2. 2
    Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike protein vaccine: a randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study)

    المؤلفون: Juan M. Fernández-Ávila, Jorge L. Azor-Hernández, Cristina O. Chávez-Chong, Klaudia Urrutia-Pérez, Lianne del Toro-Lahera, Joel Quintana-Guerra, Verena Muzio-Gonzalez, Enrique Noa-Romero, Yenima Martín-Bauta, Sergio del Valle-Piñera, Elisangela Tablada-Ferreiro, Rossana Remedios-Reyes, Gilda Lemos-Pérez, Zadis Navarro-Rodríguez, Marjoris Piñera-Martínez, Jacqueline Bizet-Almeida, Nabil A. Ali-Mros, Francisco Hernández-Bernal, Leonardo Lobaina-Lambert, Mayara Ramírez-Domínguez, José L. Rodríguez-Reinoso, Karen Urrutia-Pérez, Miladys Limonta-Fernández, Maria C. Ricardo-Cobas, Marel Alonso-Valdes, Ariel Palenzuela-Díaz, Marta Ayala-Ávila, Jeniffer Rodríguez-Nuviola, Elizabeth Colina-Ávila

    مصطلحات موضوعية: Clinical trial, Vaccination, medicine.medical_specialty, Titer, business.industry, Vaccination schedule, Internal medicine, Immunogenicity, medicine, Seroconversion, Adverse effect, Placebo, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::bf87421192211cec367a7be6eaf1bd68
    https://doi.org/10.1101/2021.11.30.21267047

    View record in OpenAIRE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء